| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016208683 |
| P356 | DOI | 10.1291/HYPRES.26.847 |
| P953 | full work available at URL | https://www.jstage.jst.go.jp/article/hypres/26/10/26_10_847/_pdf |
| P698 | PubMed publication ID | 14621189 |
| P50 | author | Koichiro Kuwahara | Q93052185 |
| Yoshihiro Ogawa | Q96682708 | ||
| P2093 | author name string | Yoshihiko Saito | |
| Kazuwa Nakao | |||
| Masaki Harada | |||
| Michio Nakanishi | |||
| Nobuki Takahashi | |||
| Rika Kawakami | |||
| Yasuaki Nakagawa | |||
| Ichiro Kishimoto | |||
| P2860 | cites work | American Journal of Physiology | Q2160146 |
| Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload | Q28285683 | ||
| Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload | Q28568167 | ||
| The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo | Q31805061 | ||
| Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? | Q33585721 | ||
| Summary of randomized trials of angiotensin converting enzyme inhibitors | Q33697681 | ||
| Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene | Q34142903 | ||
| A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression | Q34440843 | ||
| Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family | Q34453631 | ||
| Cardiac fibrosis in mice lacking brain natriuretic peptide | Q35677878 | ||
| Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide | Q35915041 | ||
| Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade | Q38547301 | ||
| Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway | Q39576736 | ||
| Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells | Q40799480 | ||
| Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice | Q40849726 | ||
| Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide | Q41273237 | ||
| Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy | Q42130562 | ||
| Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension | Q42280521 | ||
| Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogen-activated protein kinases in cultured cardiac myocytes | Q42508825 | ||
| Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. | Q43505207 | ||
| Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability | Q43978629 | ||
| Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart | Q44149445 | ||
| Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. | Q46009276 | ||
| The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. | Q46028223 | ||
| Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group | Q48167953 | ||
| Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man | Q48370412 | ||
| Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure | Q48643573 | ||
| Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial | Q48829448 | ||
| Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. | Q53759460 | ||
| Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. | Q53907769 | ||
| ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis | Q63684407 | ||
| Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells | Q70870940 | ||
| Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis | Q71571336 | ||
| Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats | Q71933803 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| internal medicine | Q11180 | ||
| overexpression | Q61643320 | ||
| Cardiology and cardiovascular medicine | Q96320350 | ||
| P304 | page(s) | 847-853 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Hypertension Research | Q15762136 |
| P1476 | title | Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation | |
| P478 | volume | 26 |
| Q92177448 | B-Type Cardiac Natriuretic Peptides in the Neonatal and Pediatric Intensive Care Units |
| Q38324210 | BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? |
| Q54705010 | Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27. |
| Q36350919 | Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. |
| Q53214797 | LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice. |
| Q36129944 | Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion |
| Q26778333 | Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events |
| Q36050919 | Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury |
| Q34044364 | Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. |
| Q37869374 | The paradox of low BNP levels in obesity |
| Q49030574 | The protective effects of 17beta-estradiol against ischemia-reperfusion injury and its effect on pacing postconditioning protection to the heart |
Search more.